dreamm trial update - blenrep in myeloma trials | natalie callander, md | ash 2021
Published 2 years ago • 371 plays • Length 3:35Download video MP4
Download video MP3
Similar videos
-
8:28
dreamm‑3 - blenrep (belmaf) vs pomdex for relapsed/refractory myeloma | katja weisel, md | asco 2023
-
0:48
final analysis of the dreamm-2 trial: belantamab mafodotin for r/r multiple myeloma
-
5:38
dreamm-6: safety and tolerability of belantamab mafodotin in combination with bortezomib/dex in rrmm
-
0:58
belantamab mafodotin: a potential new soc in second-line myeloma based on the dreamm trials
-
3:19
bcma-targeted therapy in rrmm: results from the dreamm-1 trial
-
52:45
current treatment options - stephen ansell, md
-
3:25
belantamab mafodotin and its place in myeloma treatment
-
10:42
what is new in melanoma?
-
3:59
dreamm-9: phase i study of belantamab mafodotin standard of care in pts w/transplant-ineligible ndmm
-
6:42
dreamm-5 platform trial: belantamab mafodotin in combination with novel agents in patients with rrmm
-
2:40
what's new in multiple myeloma clinical research?
-
4:44
dreamm-3 and belantamab mafodotin, a new myeloma drug
-
15:46
dreamm-8: belantamab mafodotin pomalidomide and dex shows improved outcomes in rr multiple myeloma
-
1:02
dreamm-3: safety of belantamab mafodotin versus pom/dex in patients with r/r myeloma
-
1:36
dreamm-2: belantamab mafodotin for r/r myeloma
-
0:52
combining pembrolizumab with bcr inhibitors for richter's transformation
-
1:59
dreamm-2: update on belantamab mafodotin in r/r myeloma
-
2:02
milner consortium call 2023
-
4:58
dreamm-2: single-agent belantamab mafodotin in patients with rrmm and renal impairment
-
6:09
dreamm-2: effects of belantamab mafodotin on patient reported outcomes in myeloma
-
1:44
the role of belantamab mafodotin in multiple myeloma: the dreamm-7 and dreamm-8 trials
-
3:04
dreamm-3: belantamab mafodotin vs pom/dex for r/r myeloma